BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 12838316)

  • 1. RARRES3 expression positively correlated to tumour differentiation in tissues of colorectal adenocarcinoma.
    Shyu RY; Jiang SY; Chou JM; Shih YL; Lee MS; Yu JC; Chao PC; Hsu YJ; Jao SW
    Br J Cancer; 2003 Jul; 89(1):146-51. PubMed ID: 12838316
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RARRES1 expression is significantly related to tumour differentiation and staging in colorectal adenocarcinoma.
    Wu CC; Shyu RY; Chou JM; Jao SW; Chao PC; Kang JC; Wu ST; Huang SL; Jiang SY
    Eur J Cancer; 2006 Mar; 42(4):557-65. PubMed ID: 16426842
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decreased expression of type II tumor suppressor gene RARRES3 in tissues of hepatocellular carcinoma and cholangiocarcinoma.
    Jiang SY; Chou JM; Leu FJ; Hsu YY; Shih YL; Yu JC; Lee MS; Shyu RY
    World J Gastroenterol; 2005 Feb; 11(7):948-53. PubMed ID: 15742394
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Immunohistochemical expression of endothelial cell differentiation gene-2 receptor in human colorectal adenomas.
    Komuro Y; Watanabe T; Kitayama J; Yamaguchi H; Tsuno N; Nagawa H
    Hepatogastroenterology; 2003; 50(54):1770-3. PubMed ID: 14696401
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of SIRT1 histone deacetylase expression associates with tumour progression in colorectal adenocarcinoma.
    Jang SH; Min KW; Paik SS; Jang KS
    J Clin Pathol; 2012 Aug; 65(8):735-9. PubMed ID: 22554968
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DMBT1 expression and glycosylation during the adenoma-carcinoma sequence in colorectal cancer.
    Robbe C; Paraskeva C; Mollenhauer J; Michalski JC; Sergi C; Corfield A
    Biochem Soc Trans; 2005 Aug; 33(Pt 4):730-2. PubMed ID: 16042587
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The nuclear to cytoplasmic shift of ING5 protein during colorectal carcinogenesis with their distinct links to pathologic behaviors of carcinomas.
    Zheng HC; Xia P; Xu XY; Takahashi H; Takano Y
    Hum Pathol; 2011 Mar; 42(3):424-33. PubMed ID: 21193223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TPX2 and AURKA promote 20q amplicon-driven colorectal adenoma to carcinoma progression.
    Sillars-Hardebol AH; Carvalho B; Tijssen M; Beliën JA; de Wit M; Delis-van Diemen PM; Pontén F; van de Wiel MA; Fijneman RJ; Meijer GA
    Gut; 2012 Nov; 61(11):1568-75. PubMed ID: 22207630
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Association of galectin-3 expression with biological behaviors of human colorectal carcinoma].
    Zhang N; Ding YQ; Liang L
    Nan Fang Yi Ke Da Xue Xue Bao; 2006 Dec; 26(12):1685-9. PubMed ID: 17259097
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aberrant SERCA3 expression during the colorectal adenoma-adenocarcinoma sequence.
    Gou WF; Niu ZF; Zhao S; Takano Y; Zheng HC
    Oncol Rep; 2014 Jan; 31(1):232-40. PubMed ID: 24213720
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of microRNA-1288 in colorectal cancer: altered expression and its clinicopathological significance.
    Gopalan V; Pillai S; Ebrahimi F; Salajegheh A; Lam TC; Le TK; Langsford N; Ho YH; Smith RA; Lam AK
    Mol Carcinog; 2014 Feb; 53 Suppl 1():E36-44. PubMed ID: 24009195
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The angiogenic switch for vascular endothelial growth factor (VEGF)-A, VEGF-B, VEGF-C, and VEGF-D in the adenoma-carcinoma sequence during colorectal cancer progression.
    Hanrahan V; Currie MJ; Gunningham SP; Morrin HR; Scott PA; Robinson BA; Fox SB
    J Pathol; 2003 Jun; 200(2):183-94. PubMed ID: 12754739
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevated expression of Bcl-X and reduced Bak in primary colorectal adenocarcinomas.
    Krajewska M; Moss SF; Krajewski S; Song K; Holt PR; Reed JC
    Cancer Res; 1996 May; 56(10):2422-7. PubMed ID: 8625322
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of IGF-1R in colorectal polyps and its role in colorectal carcinogenesis.
    Shan HB; Zhang R; Li Y; Xu GL; Luo GY; Gao XY; Yang HL
    Technol Cancer Res Treat; 2011 Aug; 10(4):381-9. PubMed ID: 21728395
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical impacts of mammalian target of rapamycin expression in human colorectal cancers.
    Alqurashi N; Gopalan V; Smith RA; Lam AK
    Hum Pathol; 2013 Oct; 44(10):2089-96. PubMed ID: 23773481
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TGF-beta1 in colonic neoplasia: a genetic molecular and immunohistochemical study.
    Cardillo MR; Yap E
    J Exp Clin Cancer Res; 1997 Sep; 16(3):281-8. PubMed ID: 9387902
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of cytokeratins 7 and 20 in serrated adenoma and related diseases.
    Tatsumi N; Mukaisho K; Mitsufuji S; Tatsumi Y; Sugihara H; Okanoue T; Hattori T
    Dig Dis Sci; 2005 Sep; 50(9):1741-6. PubMed ID: 16133982
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Expression of beta-catenin in human colorectal adenoma and carcinoma].
    Huang Q; Zhu YM; Xing XM; Lai MD
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2004 Mar; 33(2):121-4. PubMed ID: 15067731
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The clinicopathological significance of REIC expression in colorectal carcinomas.
    Wang W; Zhu W; Xu XY; Nie XC; Yang X; Xing YN; Yu M; Liu YP; Takano Y; Zheng HC
    Histol Histopathol; 2012 Jun; 27(6):735-43. PubMed ID: 22473694
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ADAM-17/FHL2 colocalisation suggests interaction and role of these proteins in colorectal cancer.
    Verset L; Tommelein J; Decaestecker C; De Vlieghere E; Bracke M; Salmon I; De Wever O; Demetter P
    Tumour Biol; 2017 Mar; 39(3):1010428317695024. PubMed ID: 28349819
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.